Form 4: Parabilis Medicines Insider Buys Shares
Insider Transaction (Form 4)
Ra Capital Management, L.P. and 4 others reported changes in beneficial ownership of Parabilis Medicines, Inc. common stock on July 20, 2026.
Summary
- Open-market purchase: acquired 98,433 Voting Common Stock at $27.13 ($2,670,487) on July 20, 2026; holds 26,383,526 after (Indirect).
- Open-market purchase: acquired 32,987 Voting Common Stock at $27.72 ($914,400) on July 20, 2026; holds 26,416,513 after (Indirect).
- Open-market purchase: acquired 21,696 Voting Common Stock at $27.96 ($606,620) on July 21, 2026; holds 26,438,209 after (Indirect).
- Open-market purchase: acquired 6,504 Voting Common Stock at $29.17 ($189,722) on July 21, 2026; holds 26,444,713 after (Indirect).
- Open-market purchase: acquired 37,723 Voting Common Stock at $30.00 ($1,131,690) on July 21, 2026; holds 26,482,436 after (Indirect).
- Open-market purchase: acquired 47,250 Voting Common Stock at $29.77 ($1,406,632) on July 22, 2026; holds 26,529,686 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $6,919,551, committing personal capital to the stock.
Insider Transactions
Ra Capital Management, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund III, L.P. — Director
Peter Kolchinsky — Director, 10% owner
Rajeev M. Shah — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-20 | Open-market purchase | Voting Common Stock | 98,433 | $27 | $2.7M | 26,383,526 |
| 2026-07-20 | Open-market purchase | Voting Common Stock | 32,987 | $28 | $914.4K | 26,416,513 |
| 2026-07-21 | Open-market purchase | Voting Common Stock | 21,696 | $28 | $606.6K | 26,438,209 |
| 2026-07-21 | Open-market purchase | Voting Common Stock | 6,504 | $29 | $189.7K | 26,444,713 |
| 2026-07-21 | Open-market purchase | Voting Common Stock | 37,723 | $30 | $1.1M | 26,482,436 |
| 2026-07-22 | Open-market purchase | Voting Common Stock | 47,250 | $30 | $1.4M | 26,529,686 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-20 | Open-market purchase (98,433 shares) |
| 2026-07-20 | Open-market purchase (32,987 shares) |
| 2026-07-21 | Open-market purchase (21,696 shares) |
| 2026-07-21 | Open-market purchase (6,504 shares) |
| 2026-07-21 | Open-market purchase (37,723 shares) |
| 2026-07-22 | Open-market purchase (47,250 shares) |
Keywords
insider transaction, Form 4, PBLS, Parabilis Medicines, Inc., bullish, Ra Capital Management, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund III, L.P., Peter Kolchinsky, Rajeev M. Shah
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.